StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · COCH·Healthcare

Envoy Medical, Inc. Stock Analysis & AI Score

Envoy Medical, Inc. (COCH) has an ST Score of 45.4 (C+), driven by its Forecast (A) and held back by its Profitability (D). Analysts rate it Buy with a $2.00 price target (+179.3% upside).

Market Closed
$0.72
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
45
ST Score
45.4/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

COCH
45.4out of 100
Grade C+

Envoy Medical, Inc. (COCH) has an ST Score of 45.4 (C+), driven by its Forecast (A) and held back by its Profitability (D). Analysts rate it Buy with a $2.00 price target (+179.3% upside).

Strongest
ForecastA
Weakest
ProfitabilityD
All factor grades
  • ForecastA
  • MomentumB
  • ValuationC
  • Financial StrengthC
  • GrowthC
  • ProfitabilityD
  • Piotroski3/9
Score methodology
Press Releases

Contact

COCH stock: frequently asked questions

What is COCH's ST Score?

Envoy Medical, Inc. (COCH) has an ST Score of 45.4 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is COCH a buy, hold, or sell?

Analysts rate COCH a Buy, with a price target of $2.00 (+179.3% vs the current price). Our ST Score grades it C+ (45.4/100). The ST Score is a data-driven signal, not a recommendation.

What are COCH's factor grades?

Valuation C, Profitability D, Financial Strength C, Momentum B, Growth C, Forecast A.

What is COCH's valuation grade?

Envoy Medical, Inc. (COCH) earns a valuation grade of C, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is COCH's growth grade?

Envoy Medical, Inc. (COCH) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is COCH's profitability grade?

Envoy Medical, Inc. (COCH) earns a profitability grade of D, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is COCH's financial strength grade?

Envoy Medical, Inc. (COCH) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for COCH?

The average analyst price target for Envoy Medical, Inc. (COCH) is $2.00 from 3 analysts, which is +179.3% versus the recent price of $0.72.

What is COCH's Piotroski score?

Envoy Medical, Inc. (COCH) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.